SCHEMBL16780939

SCHEMBL16780939

CC(C(=O)NC(Cc1ccc(N)cc1)C(=O)N1C[Si](C)(C)CC1C(=O)NC1CCCc2ccccc21)N(C)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
XIAP P98170 19/20 0.57
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16780938 1.00 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16780666 1.00 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16780937 1.00 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16780667 1.00 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16780577 0.93 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16780578 0.93 XIAP (0.57) XIAPMEN1HTTKMT2A
SCHEMBL16807539 0.91 XIAP (0.57) XIAP
SCHEMBL15424867 0.91 XIAP (0.57) XIAP
SCHEMBL15566309 0.88 XIAP (0.55) XIAP
SCHEMBL15566313 0.88 XIAP (0.55) XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872521-B1 IAP ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2016-08-24 EP disclosed
US-9345740-B2 IAP antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2016-05-24 US disclosed
US-20150164974-A1 IAP ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY 2015-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164974-A1 IAP ANTAGONISTS XIAP, BIRC5, API5 XIAP 1/4885MEN1 3059/4885HTT 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.